NovaBridge Biosciences (NBP)
NASDAQ: NBP · Real-Time Price · USD
1.860
+0.090 (5.08%)
At close: May 26, 2026, 4:00 PM EDT
1.940
+0.080 (4.28%)
After-hours: May 26, 2026, 7:59 PM EDT
NovaBridge Biosciences Market Cap
NovaBridge Biosciences has a market cap or net worth of $215.11 million as of May 26, 2026. Its market cap has increased by 199.92% in one year.
Market Cap
215.11M
Enterprise Value
7.33M
1-Year Change
199.92%
Ranking
Category
Stock Price
$1.86
Market Cap Chart
Since January 17, 2020, NovaBridge Biosciences's market cap has increased from $138.05M to $215.11M, an increase of 55.82%. That is a compound annual growth rate of 7.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 26, 2026 | 215.11M | -53.12% |
| Dec 31, 2025 | 458.86M | 562.90% |
| Dec 31, 2024 | 69.22M | -56.10% |
| Dec 29, 2023 | 157.68M | -54.60% |
| Dec 30, 2022 | 347.35M | -90.48% |
| Dec 31, 2021 | 3.65B | 9.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NervGen Pharma | 218.26M |
| Nkarta | 216.78M |
| Unicycive Therapeutics | 215.74M |
| MediWound | 213.09M |
| Caribou Biosciences | 206.34M |
| Tonix Pharmaceuticals Holding | 203.56M |
| Corbus Pharmaceuticals Holdings | 201.31M |
| Arcturus Therapeutics Holdings | 199.81M |